EVA1A and metabolic dysfunction-associated steatotic liver disease: In our previous HFD-induced MASLD mouse model, the protein levels and transcript levels of hepatic Eva1a were confirmed to be significantly down-regulated compared with those in NCD-fed mice (Fig. 1B and C).